TME-targeted approaches of brain metastases and its clinical therapeutic evidence.
Frontiers In Immunology
Khan, Ibrar Muhammad IM; Khan, Safir Ullah SU; Sala, Hari Siva Sai HSS; Khan, Munir Ullah MU; Ud Din, Muhammad Azhar MA; Khan, Samiullah S; Hassan, Syed Shams Ul SSU; Khan, Nazir Muhammad NM; Liu, Yong Y
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
Journal For Immunotherapy Of Cancer
Chesney, Jason A JA; Puzanov, Igor I; Collichio, Frances A FA; Singh, Parminder P; Milhem, Mohammed M MM; Glaspy, John J; Hamid, Omid O; Ross, Merrick M; Friedlander, Philip P; Garbe, Claus C; Logan, Theodore T; Hauschild, Axel A; Lebbé, Celeste C; Joshi, Harshada H; Snyder, Wendy W; Mehnert, Janice M JM
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Frontiers In Oncology
Trinder, Sarah M SM; McKay, Campbell C; Power, Phoebe P; Topp, Monique M; Chan, Bosco B; Valvi, Santosh S; McCowage, Geoffrey G; Govender, Dinisha D; Kirby, Maria M; Ziegler, David S DS; Manoharan, Neevika N; Hassall, Tim T; Kellie, Stewart S; Heath, John J; Alvaro, Frank F; Wood, Paul P; Laughton, Stephen S; Tsui, Karen K; Dodgshun, Andrew A; Eisenstat, David D DD; Endersby, Raelene R; Luen, Stephen J SJ; Koh, Eng-Siew ES; Sim, Hao-Wen HW; Kong, Benjamin B; Gottardo, Nicholas G NG; Whittle, James R JR; Khuong-Quang, Dong-Anh DA; Hansford, Jordan R JR
Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4 + Anti-PD-1 Therapy.
Journal Of Immunotherapy (Hagerstown, Md. : 1997)
Buchbinder, Elizabeth I EI; Pfaff, Kathleen L KL; Turner, Madison M MM; Manos, Michael M; Ouyang, Olivia O; Ott, Patrick A PA; Giobbie-Hurder, Anita A; Rodig, Scott J SJ; Hodi, F Stephen FS
A Complex of Pyrosequencing-Based Methods for Detection of Somatic Mutations in Codons 600 and 601 of the BRAF gene.
Sovremennye Tekhnologii V Meditsine
Dribnokhodova, O P OP; Esman, A S AS; Korchagin, V I VI; Bukharina, A Yu AY; Dunaeva, E A EA; Leshkina, G V GV; Borisova, E V EV; Voiciehovskaya, Ya A YA; Daoud, A I AI; Khlyavich, V N VN; Mironov, K O KO
Publication Date: 2022
Variant appearance in text: BRAF: 1798_1799delinsAA
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Nature Medicine
Subbiah, Vivek V; Kreitman, Robert J RJ; Wainberg, Zev A ZA; Gazzah, Anas A; Lassen, Ulrik U; Stein, Alexander A; Wen, Patrick Y PY; Dietrich, Sascha S; de Jonge, Maja J A MJA; Blay, Jean-Yves JY; Italiano, Antoine A; Yonemori, Kan K; Cho, Daniel C DC; de Vos, Filip Y F L FYFL; Moreau, Philippe P; Fernandez, Elena Elez EE; Schellens, Jan H M JHM; Zielinski, Christoph C CC; Redhu, Suman S; Boran, Aislyn A; Passos, Vanessa Q VQ; Ilankumaran, Palanichamy P; Bang, Yung-Jue YJ
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.
Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.
Cancers
Markou, A N AN; Londra, D D; Stergiopoulou, D D; Vamvakaris, I I; Potaris, K K; Pateras, I S IS; Kotsakis, A A; Georgoulias, V V; Lianidou, E E
Publication Date: 2023-03-21
Variant appearance in text: BRAF: 1798_1799delinsAA
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.
Nature Communications
Lim, Su Yin SY; Shklovskaya, Elena E; Lee, Jenny H JH; Pedersen, Bernadette B; Stewart, Ashleigh A; Ming, Zizhen Z; Irvine, Mal M; Shivalingam, Brindha B; Saw, Robyn P M RPM; Menzies, Alexander M AM; Carlino, Matteo S MS; Scolyer, Richard A RA; Long, Georgina V GV; Rizos, Helen H
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.
Targeted Oncology
Piejko, Karolina K; Cybulska-Stopa, Bożena B; Ziętek, Marcin M; Dziura, Robert R; Galus, Łukasz Ł; Kempa-Kamińska, Natasza N; Ziółkowska, Barbara B; Rutkowska, Ewa E; Kopciński, Tomasz T; Kubiatowski, Tomasz T; Bal, Wiesław W; Suwiński, Rafał R; Mackiewicz, Jacek J; Kamińska-Winciorek, Grażyna G; Czarnecka, Anna M AM; Rutkowski, Piotr P
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data.
Cancers
Derks, Sophie H A E SHAE; Jongen, Joost L M JLM; van der Meer, Edgar L EL; Ho, Li Shen LS; Slagter, Cleo C; Joosse, Arjen A; de Jonge, Maja J A MJA; Schouten, Joost W JW; Oomen-de Hoop, Esther E; van den Bent, Martin J MJ; van der Veldt, Astrid A M AAM
Network expansion of genetic associations defines a pleiotropy map of human cell biology.
Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23
Variant appearance in text: BRAF: 1798_1799delinsAA
Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure.
Cns Oncology
Tringale, Kathryn R KR; Reiner, Anne S AS; Sehgal, Ryka R RR; Panageas, Katherine K; Betof Warner, Allison S AS; Postow, Michael A MA; Moss, Nelson S NS